miR-29a/b also target several proteins involved in neurodegenerative diseases, including BACE1/β-secretase, of which elevated levels can lead to increased amyloid β-peptides in patients with sporadic Alzheimer’s disease (Hebert et al. 2008). The gene discussed is BACE1; the disease is neurodegenerative disease.